4 active not recruiting, 2 completed, 2 enrolling by invitation, 1 not yet recruiting. 12 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 12 | Active not recruiting 4, Completed 2, Enrolling by invitation 2, Not yet recruiting 1, Recruiting 1, Unknown 1, Withdrawn 1 |
Follow Xeltis: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| XPAD European Feasibility Study XPAD conduit - Peripheral Arterial Disease | Not applicable | Not yet recruiting | Xeltis | 15 | 2026-12-01 | 2026-07-21 |
| Xeltis Peripheral Artery Disease (XPAD) Bypass Conduit Early Feasibility Study Xeltis Peripheral Artery Disease (XPAD) Bypass Conduit - Peripheral Artery Occlusive Disease | Not applicable | Active not recruiting | Xeltis | 6 | 2025-05-02 | 2026-10-06 |
| Xeltis Hemodialysis Access (aXess) Conduit: aXess-E Study aXess-E conduit - End Stage Renal Disease | Not applicable | Recruiting | Xeltis | 20 | 2024-12-16 | 2026-07-29 |
| Xeltis Hemodialysis Access Graft (aXess) US Study Xeltis Hemodialysis Access (aXess) graft - End Stage Renal Disease | Not applicable | Enrolling by invitation | Xeltis | 140 | 2024-11-11 | 2026-07-29 |
| Xeltis Hemodialysis Access Graft: aXess Pivotal Study Xeltis Hemodialysis Access (aXess) graft - End-stage Renal Disease | Not applicable | Active not recruiting | Xeltis | 120 | 2022-11-04 | 2025-07-18 |
| First-in-Human (FIH) Study of the Xeltis Hemodialysis Access Graft aXess - End Stage Renal Disease, End Stage Renal Failure on Dialysis | Not applicable | Active not recruiting | Xeltis | 20 | 2021-06-10 | 2025-07-10 |
| Xeltis Coronary Artery Bypass Graft (XABG) First in Human (FIH) CABG - Multi Vessel Coronary Artery Disease | Not applicable | Enrolling by invitation | Xeltis | 20 | 2020-10-22 | 2026-07-29 |
| Xeltis Pulmonary Valved Conduit Safety and Performance Study Xeltis Pulmonary Valved Conduit - Heart Defects, Congenital | Not applicable | Withdrawn | Xeltis | 2020-09-01 | 2021-04-09 | |
| Xeltis Bioabsorbable Pulmonary Valved Conduit Pivotal Study Xeltis Bioabsorbable Pulmonary Valved Conduit - Heart Defect, Congenital | Not applicable | Active not recruiting | Xeltis | 6 | 2017-05-08 | 2026-08-06 |
| Study to Assess Safety of the Pulmonary Valved Conduit (PV-001) in Subjects Undergoing Right Ventricular Outflow Tract Reconstruction Bioabsorbable Pulmonary Valved Conduit (PV-001) - Congenital Heart Disease | Not applicable | Unknown | Xeltis | 12 | 2016-06-01 | 2021-04-08 |
| Safety and Performance of a Vascular Patch in Pediatric Patients Undergoing Bidirectional Cava-pulmonary Anastomosis Xeltis Vascular Patch, Model COR-VP-001 - Heart Defects, Congenital | Not applicable | Completed | Xeltis | 5 | 2014-06-01 | 2020-11-19 |
| Safety and Performance of the COR-VG-001 Conduit in Pediatric Patients for Extracardiac Total Cavopulmonary Connection Vascular Graft, Model COR-VG-001 - Heart Defects, Congenital | Not applicable | Completed | Xeltis | 5 | 2013-10-01 | 2020-11-10 |
Heart Defects, Congenital (5) · Kidney Failure, Chronic (4) · Peripheral Arterial Disease (1) · Peripheral Arterial Occlusive Disease 1 (1)
Transplantation (2) · Vascular Grafting (1)
Poland (5) · Belgium (3) · Malaysia (3) · Hungary (2) · Italy (2) · Latvia (2) · Lithuania (2) · Portugal (2) · Russia (2) · United States (2) · Bulgaria (1) · Costa Rica (1) · Germany (1) · Greece (1) · Serbia (1)
Leo Bockeria, Professor (2) · An de Vriese, Dr (1) · Bart Meuris, MD (1) · Eliane Schutte (1) · Frank Vermassen, MD (1) · Mauro Gargiulo, Prof (1) · Thierry Carrel, MD (1)